These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8150600

  • 1. Cardiovascular effects of nisoldipine in essential hypertension.
    Blau A, Herzog D, Herz I, Battler A, Schechter P, Eliahou HE.
    Isr J Med Sci; 1994 Feb; 30(2):139-45. PubMed ID: 8150600
    [Abstract] [Full Text] [Related]

  • 2. Acute hemodynamic effects of nisoldipine in young hypertensive patients.
    Zimlichman R, Zilberman D, Gold B.
    Isr J Med Sci; 1995 May; 31(5):288-92. PubMed ID: 7759224
    [Abstract] [Full Text] [Related]

  • 3. Central hemodynamic effects at rest and during exercise of acute and chronic treatment with nisoldipine in essential hypertension.
    Omvik P, Lund-Johansen P, Haugland H.
    J Cardiovasc Pharmacol; 1987 May; 10 Suppl 10():S182-4. PubMed ID: 2455128
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S, Eich RH, Obeid AI, Smulyan H.
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [Abstract] [Full Text] [Related]

  • 5. Effect of nisoldipine on ambulatory blood pressure under 24-hour noninvasive monitoring.
    Blau A, Herzog D, Shechter P, Eliahou HE.
    Isr J Med Sci; 1992 Oct; 28(10):688-93. PubMed ID: 1399498
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension.
    Chamiec T, Bednarz B, Budaj A, Kłoś J, Pietrzykowska H, Zaleska T, Ceremuzyński L.
    Mater Med Pol; 1990 Oct; 22(3):188-90. PubMed ID: 2132424
    [Abstract] [Full Text] [Related]

  • 9. Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance.
    Fagan TC, Gourley LA, Sawyer PR, Lee JT, Walle T, Gaffney TE.
    J Clin Hypertens; 1986 Mar; 2(1):21-9. PubMed ID: 3723158
    [Abstract] [Full Text] [Related]

  • 10. The effects of nisoldipine, diltiazem, nifedipine, and verapamil on hemodynamic parameters and red blood cells-platelet interactions in patients with arterial hypertension.
    Belousov Y, Kushnaryov V.
    J Cardiovasc Pharmacol; 1991 Mar; 18 Suppl 9():S32-5. PubMed ID: 1725540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Haemodynamic effects of nisoldipine by oral route.
    Razzolini R, Boffa GM, Calvanese A, Isabella G, Ramondo A, Chioin R.
    Pharmacol Res; 1991 Oct; 24(3):257-62. PubMed ID: 1956870
    [Abstract] [Full Text] [Related]

  • 19. Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences.
    Chrysant SG, Dunn FG, De Carvalho JG, Adamopoulos PN, Frolich ED.
    Arch Intern Med; 1977 Dec; 137(12):1702-5. PubMed ID: 412475
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
    Tsuchiya M.
    Jpn Circ J; 1972 Mar; 36(3):275-88. PubMed ID: 5068095
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.